Rheumatoid arthritis in Latin America: pharmacotherapy and clinical challenges
Authors:
- 10 October 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 25 (15) , 2023-2033
Abstract
Rheumatoid arthritis (RA) presents significant healthcare challenges in Latin America (LA) due to its high prevalence and unique healthcare dynamics. Despite global advancements, LA faces specific hurdles in managing RA effectively. This manuscript reviews the epidemiology, pharmacotherapies, and clinical challenges of RA in LA. RA prevalence varies, with higher rates in indigenous populations. Treatment guidelines recommend conventional disease-modifying antirheumatic drugs (csDMARDs) as first-line therapy, but access is inconsistent. Biologics, and targeted synthetic DMARDs, are available in most LA countries, though biosimilars are less accessible, with significant variations in drug prices. Barriers to treatment include supply interruptions, diagnosis delays, and high non-adherence rates linked to socioeconomic factors. The severe shortage of rheumatologists, especially in rural areas, impacts patient outcomes. Cardiovascular events and, other comorbidities and endemic infections, further complicate RA management in LA. LA has seen improvements in RA management with better use of csDMARDs, treat-to-target strategies, and advanced treatments. However, challenges remain, including the shortage of rheumatologists, limited continuous medical education, endemic infections, and fragmented healthcare systems. Addressing these issues requires expanding training programs, leveraging telemedicine, and ensuring consistent drug supply. Enhancing clinical research and local data information and improving access to affordable treatments are crucial for better patient outcomes. Comprehensive, region-specific strategies are needed to bridge the gap between LA and more developed regions in RA care.Keywords
This publication has 93 references indexed in Scilit:
- Impact of access to treatment on patient‐reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin‐American countries: A prospective observational studyHealth Science Reports, 2023
- Rheumatoid arthritis in Latin America: the importance of an early diagnosisClinical Rheumatology, 2015
- Proper management of rheumatoid arthritis in Latin America. What the guidelines say?Clinical Rheumatology, 2015
- Access to an optimal treatment. Current situationClinical Rheumatology, 2015
- Effects of cigarette smoking on early arthritis: a cross-sectional study—data from the Argentine Consortium for Early Arthritis (CONAART)Rheumatology International, 2014
- Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in ArgentinaClinical Rheumatology, 2014
- Early rheumatoid arthritis in Latin America: Low socioeconomic status related to high disease activity at baselineArthritis Care & Research, 2012
- Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritisRheumatology International, 2010
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002
- Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty‐year periodArthritis & Rheumatism, 2002